We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




First Light Field-Enabled Spine Surgery Navigation Platform Reduces Need for Intraoperative Radiation

By HospiMedica International staff writers
Posted on 26 Apr 2023

The surgical ecosystem urgently requires innovative technology to deliver insightful, real-time information to surgeons, operating room staff, and hospitals. An advanced surgical navigation platform now combines light field technology, computer vision, data intelligence, and real-time anatomical alignment calculations to ensure surgeons have access to the most comprehensive information during operations.

Proprio’s (Seattle, WA, USA) Paradigm platform is the first to employ light field technology for spine surgery navigation, generating a real-time 3D view of the anatomy and surgical scene. The system utilizes a sophisticated sensor suite to capture high-definition, multimodal intraoperative images, which are then combined with preoperative scans. This technology enables surgeons to access valuable data, including intraoperative imaging and enhanced visualization capabilities, without harmful radiation or interference with their workflow. Proprio refers to this data fusion feature as Volumetric Intelligence.

Paradigm offers surgical teams solutions that address many of the clinical frustrations and challenges currently plaguing surgery. It eliminates the need for high-radiation intraoperative scans during the procedure, resulting in a 10x reduction in radiation exposure. The platform also removes the need for intraoperative scans, reducing the workflow by up to 30 minutes per procedure. Traditional intraoperative scans require a registration process that can take 15 to 30 minutes, while Paradigm's registration can be completed in mere seconds. Moreover, Paradigm can collect an enormous amount of data, capturing approximately 250GB per hour. This invaluable data informs Proprio's product development and advances models for future applications. The Paradigm platform has received 510(k) clearance from the U.S. Food and Drug Administration (FDA).

"We are very enthusiastic about the potential for Paradigm to enable clinicians to revolutionize spine surgery," said Gabriel Jones, CEO and Co-Founder of Proprio. "We're reimagining how surgery is done, rather than reconfiguring legacy tools. This uniquely positions our system to effectively capture the valuable data needed to feed advanced computer vision and deep learning models to recognize, track and analyze complex anatomical structures. The potential of this technology in the hands of skilled clinicians has us all very optimistic about the future of surgical practice."

Related Links:
Proprio 

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
12-Channel ECG
CM1200B
New
Multifunctional Patient Floor Lift
Maxi Move 5
New
Mobile X-Ray Machine
MARS 15 / 30
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: Samples of heart tissue from the study (Photo courtesy of Nathan Gianneschi/Northwestern University)

New Potent Injectable Therapy Could Prevent Heart Failure After Heart Attack

According to the U.S. Centers for Disease Control and Prevention, 6.7 million Americans aged 20 and older are living with heart failure, a condition in which the heart cannot pump enough blood to meet... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.